Background: We aim to retrospectively explore the guiding value of the Lauren classification for patients who have undergone D2 gastrectomy to choose oxaliplatin plus capecitabine (XELOX) or oxaliplatin plus S-1 (SOX) as a further systemic treatment after the operation.
Methods: We collected data of 406 patients with stage III gastric cancer(GC)after radical D2 resection and regularly received XELOX or SOX adjuvant treatment after surgery and followed them for at least five years. According to the Lauren classification, we separated patients out into intestinal type (IT) GC together with non-intestinal type(NIT) GC. According to the chemotherapy regimen, we separated patients into the SOX group together with the XELOX group.
Results: Among non-intestinal type patients, the 3-year DFS rates in the SOX group and the XELOX group were 72.5%, respectively; 54.5% (P=0.037); The 5-year OS rates were 66.8% and 51.8% respectively (P=0.038), both of which were statistically significant.
Conclusion: The patients of non-intestinal type GC may benefit from the SOX regimen. Differences were counted without being statistically significant with intestinal-type GC in the SOX or XELOX groups.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/0115665232247694230921060213 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development and validation of a preoperative model for predicting positive proximal margins in adenocarcinoma of the esophagogastric junction and assessing safe margin distance.
Front Oncol
December 2024
Department of Gastrointestinal, Hengshui People's Hospital, Hengshui, Hebei, China.
Objective: To develop and validate a model for preoperative prediction of positive proximal margins for adenocarcinoma of the esophagogastric junction (AEG) by transabdominal approach, and to analyze the safe margin distances for patients with different risks of positive proximal margins.
Materials And Methods: A retrospective analysis was performed on 284 AEG patients who underwent surgery via the transabdominal approach at Hengshui People's Hospital between January 2017 and December 2023. Patients were divided into a training set (=201, first five years) and a test set (=83, last two years).
Identified VCAM1 as prognostic gene in gastric cancer by co-expression network analysis.
Discov Oncol
December 2024
Breast Cancer Center, Division of Life Sciences and Medicine,The First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China, NO. 107, West 2nd Ring Road, Hefei, Anhui, China.
The diffuse gastric cancer (DGC) is a malignant tumor distinct from intestinal gastric cancer (IGC). This study aims to identify genetic variances and potential diagnostic and therapeutic approaches for diverse types of gastric cancer utilizing an extensive dataset. Data from RNA sequencing and clinical pathological details were acquired from The Cancer Genome Atlas (TCGA) database and the Gene Expression Omnibus (GEO) dataset.
View Article and Find Full Text PDFPreoperative prediction of microvascular/nerve invasion in locally advanced gastric cancer by differentiation and enhanced CT features.
Medicine (Baltimore)
December 2024
Department of Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
The purpose of the article is to determine whether differentiation and enhanced CT features can preoperatively predict microvascular/nerve invasion in locally advanced gastric cancer. Retrospective analysis of the CT and pathological data of 325 patients with locally advanced gastric cancer confirmed by pathology in our hospital from July 2011 to August 2023. The patient's age, gender, tumor location, T stage, N stage, TNM stage, differentiation, Lauren classification, as well as tumor thickness, tumor longest diameter, plain CT value, arterial CT value, venous CT value, arterial phase enhancement rate, and venous phase enhancement rate were assessed.
View Article and Find Full Text PDFA new genus of Australian Agyrtodini from Tasmania (Coleoptera: Leiodidae: Camiarinae).
Zootaxa
May 2024
New Zealand Arthropod Collection; Maanaki Whenua Landcare Research; Private Bag 92170; Auckland; New Zealand.
Myopagyrtes tasmanicus new genus, new species, is described from Tasmania, Australia. It has reduced eyes and the hindwings are absent, unusual features among Agyrtodini. It was collected from leaf litter in forests, typically dominated by Nothofagus.
View Article and Find Full Text PDFAge-dependent trends in pediatric maxillary frenum classification.
Int J Pediatr Otorhinolaryngol
December 2024
Department of Otolaryngology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA. Electronic address:
Objective: To describe maxillary frenum Kotlow scores in a pediatric population.
Methods: A retrospective chart review was performed for children ages 0-19 years old seen at a pediatric otolaryngology clinic by one surgeon from March-December 2022. Inclusion criteria required a recorded maxillary frenum Kotlow score.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!